We are live on ! Find out more
RIGL icon

Rigel Pharmaceuticals
RIGL

120 hedge funds and large institutions have $168M invested in Rigel Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 49 increasing their positions, 30 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 30

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

1% less funds holding

Funds holding: 121 → 120 (-1)

8% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 12

32% less capital invested

Capital invested by funds: $248M → $168M (-$79.7M)

Holders
120
Holders Change
-1
Holders Change %
-0.83%
% of All Funds
3.2%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
11
Increased
49
Reduced
30
Closed
12
Calls
$27K
Puts
–
Net Calls
+$27K
Net Calls Change
-$53K

Top Buyers

1
SCM
Sio Capital Management
New York
+$3.99M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$2.67M
3
Citadel Advisors
Citadel Advisors
Florida
+$2.59M
4
DCM
DAFNA Capital Management
California
+$1.89M
5
PC
Paulson & Co
New York
+$1.16M

Top Sellers

1
BC
Broadfin Capital
New York
-$9.47M
2
Axa
Axa
France
-$5.86M
3
UBS AM
UBS AM
Illinois
-$4.12M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$2.42M
5
TC
TFS Capital
Pennsylvania
-$952K
Name Holding Trade Value Shares
Change 		Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$1.75M +$370K +15,015 +22%
ACP
27
Acuta Capital Partners
California
$1.62M +$791K +32,078 +70%
Jacobs Levy Equity Management
28
Jacobs Levy Equity Management
New Jersey
$1.48M -$94.2K -3,820 -5%
Renaissance Technologies
29
Renaissance Technologies
New York
$1.37M +$398K +16,120 +32%
State of New Jersey Common Pension Fund D
30
State of New Jersey Common Pension Fund D
New Jersey
$1.14M – – –
GC
31
Globeflex Capital
California
$935K +$1.11M +44,953 New
Bank of New York Mellon
32
Bank of New York Mellon
New York
$934K +$57.6K +2,334 +5%
Connor, Clark & Lunn Investment Management (CC&L)
33
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$893K -$76.8K -3,113 -7%
BA
34
BlackRock Advisors
Delaware
$883K +$27.9K +1,130 +3%
JGC
35
J. Goldman & Co
New York
$861K +$1.02M +41,379 New
SIM
36
Spark Investment Management
New York
$662K – – –
BIM
37
BlackRock Investment Management
Delaware
$658K -$8.88K -360 -1%
NSEDCP
38
NJ State Employees Deferred Compensation Plan
New Jersey
$645K – – –
BIM
39
Bogle Investment Management
Massachusetts
$635K -$3.43K -139 -0.5%
WMSA
40
Weiss Multi-Strategy Advisers
New York
$634K – – –
Two Sigma Advisers
41
Two Sigma Advisers
New York
$585K -$12.6K -510 -2%
AIM
42
Alambic Investment Management
California
$568K +$318K +12,880 +89%
American Century Companies
43
American Century Companies
Missouri
$513K +$313K +12,687 +106%
RFC
44
Russell Frank Company
Washington
$460K – – –
T. Rowe Price Associates
45
T. Rowe Price Associates
Maryland
$438K -$3.18K -129 -0.6%
Charles Schwab
46
Charles Schwab
California
$420K – – –
TI
47
Telemetry Investments
New York
$416K -$123K -5,000 -20%
SO
48
STRS Ohio
Ohio
$405K – – –
BCM
49
Bridgeway Capital Management
Texas
$395K -$13.1K -530 -3%
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
$388K +$57.6K +2,336 +14%
1
2
3 4 5

RIGL Hedge Fund Activity: Q1 2016 in Review

120 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q1 2016, worth a combined $168M — down 32% from $248M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of RIGL and 11 opened new positions — a net loss of 1 holder — while 30 trimmed existing stakes and 49 added.

The largest buyer was Sio Capital Management, opening a new position worth an estimated $3.99M. The largest seller was Broadfin Capital, exiting entirely with an estimated $9.47M sold.

  • 120 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q1 2016, down from 121 in Q4 2015.
  • Funds reported $168M of Rigel Pharmaceuticals stock for Q1 2016, down 32% quarter-over-quarter.
  • 11 funds opened new Rigel Pharmaceuticals positions in Q1 2016 and 12 closed out, a net change of -1 holder.
  • The largest Rigel Pharmaceuticals buyer in Q1 2016 was Sio Capital Management, an estimated $3.99M added.
  • The largest Rigel Pharmaceuticals seller in Q1 2016 was Broadfin Capital, an estimated $9.47M sold.

Based on aggregated 13F filings for Q1 2016.